​

23andMe (ME) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

23andMe Revenue Highlights

Latest Revenue (Y)

$219.64M

Latest Revenue (Q)

$40.41M

Main Segment (Y)

Consumer Services

Main Geography (Y)

UNITED STATES

23andMe Revenue by Period

23andMe Revenue by Year

DateRevenueChange
2024-03-31$219.64M-26.66%
2023-03-31$299.49M10.15%
2022-03-31$271.89M11.47%
2021-03-31$243.92M-20.15%
2020-03-31$305.46M-30.72%
2019-03-31$440.90M-

23andMe generated $219.64M in revenue during NA 2023, up -26.66% compared to the previous quarter, and up 49.82% compared to the same period a year ago.

23andMe Revenue by Quarter

DateRevenueChange
2024-06-30$40.41M-36.88%
2024-03-31$64.03M43.09%
2023-12-31$44.75M-10.50%
2023-09-30$50.00M-17.85%
2023-06-30$60.86M-34.11%
2023-03-31$92.38M38.00%
2022-12-31$66.94M-11.52%
2022-09-30$75.66M17.28%
2022-06-30$64.51M-35.85%
2022-03-31$100.56M76.76%
2021-12-31$56.89M3.06%
2021-09-30$55.20M-6.81%
2021-06-30$59.24M-33.13%
2021-03-31$88.58M59.67%
2020-12-31$55.48M7.09%
2020-09-30$51.80M7.80%
2020-06-30$48.06M-

23andMe generated $40.41M in revenue during Q1 2024, up -36.88% compared to the previous quarter, and up 43.75% compared to the same period a year ago.

23andMe Revenue Breakdown

23andMe Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 24Mar 23Mar 22
PGS$167.74M--
Consumer Services$202.31M$247.14M-
Health Care, Other$34.57M--
Research Services$27.50M$67.80M-
Service$191.82M--
Therapeutics---
K I T S-$27.70M-

23andMe's latest annual revenue breakdown by segment (product or service), as of Mar 24: Consumer Services (32.42%), Service (30.74%), PGS (26.88%), Health Care, Other (5.54%), and Research Services (4.41%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
Service$38.51M$97.07M$44.75M$50.00M$100.56M$56.89M$55.20M-----
Health Care, Other$6.42M$17.69M$7.82M$9.06M$11.53M$7.67M------
PGS$37.17M$93.07M$35.08M$39.60M$71.98M$38.37M------
Consumer Services$43.59M$88.25M$42.90M$48.66M$22.50M$10.00M$24.50M$83.51M$46.04M$44.49M$47.85M-
Research Services$26.70M$19.65M$1.85M$2.90M$3.10M$31.30M$43.40M$59.30M$17.05M$34.00M$39.90M$50.60M
Therapeutics------------

23andMe's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Consumer Services (28.60%), Service (25.27%), PGS (24.39%), Research Services (17.52%), and Health Care, Other (4.21%).

23andMe Revenue Breakdown by Country

Annual Revenue by Country

CountryMar 24Mar 23Mar 22
Other Regions$4.64M$5.64M$6.68M
CANADA$10.56M$13.58M$14.29M
UNITED STATES$180.15M$217.24M$192.44M
Research Services--$67.80M

23andMe's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (92.22%), CANADA (5.41%), and Other Regions (2.38%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
UNITED STATES$38.67M$55.42M$39.22M$42.19M$43.33M$46.77M$52.55M$48.11M$71.73M$41.74M$38.61M$40.35M
CANADA$2.40M$3.46M$2.38M$2.56M$2.17M$2.87M$2.84M$3.04M$5.24M$3.06M$2.75M$3.24M
Other Regions$1.03M$1.52M$1.01M$1.09M$1.01M$1.11M$1.24M$1.39M$2.13M$1.31M$1.51M$1.74M

23andMe's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (91.85%), CANADA (5.71%), and Other Regions (2.45%).

23andMe Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TMOThermo Fisher Scientific$42.86B$10.60B
DHRDanaher$14.03B$3.40B
AAgilent$6.83B$1.58B
ILMNIllumina$4.50B$1.08B
IDXXIDEXX Laboratories$3.66B$975.54M
WATWaters$2.96B$740.30M
GHGuardant Health$563.95M$177.24M
TWSTTwist Bioscience$312.97M$81.46M
ME23andMe$219.64M$40.41M
GENEGenetic$8.69M$3.96M

ME Revenue FAQ

What is 23andMe’s yearly revenue?

23andMe's yearly revenue for 2023 was $219.64M, representing a decrease of -26.66% compared to 2022. The company's yearly revenue for 2022 was $299.49M, representing an increase of 10.15% compared to 2021. ME's yearly revenue for 2021 was $271.89M, representing an increase of 11.47% compared to 2020.

What is 23andMe’s quarterly revenue?

23andMe's quarterly revenue for Q1 2024 was $40.41M, a -36.88% decrease from the previous quarter (Q4 2023), and a -33.60% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $64.03M, a 43.09% increase from the previous quarter (Q3 2023), and a -30.69% decrease year-over-year (Q4 2022). ME's quarterly revenue for Q3 2023 was $44.75M, a -10.50% decrease from the previous quarter (Q2 2023), and a -33.15% decrease year-over-year (Q3 2022).

What is 23andMe’s revenue growth rate?

23andMe's revenue growth rate for the last 3 years (2021-2023) was -19.22%, and for the last 5 years (2019-2023) was -28.10%.

What are 23andMe’s revenue streams?

23andMe's revenue streams in r 24 are PGS, Consumer Services, Health Care, Other, Research Services, and Service. PGS generated $167.74M in revenue, accounting 26.88% of the company's total revenue Consumer Services generated $202.31M in revenue, accounting 32.42% of the company's total revenue, down -18.14% year-over-year. Health Care, Other generated $34.57M in revenue, accounting 5.54% of the company's total revenue Research Services generated $27.5M in revenue, accounting 4.41% of the company's total revenue, down -59.44% year-over-year. Service generated $191.82M in revenue, accounting 30.74% of the company's total revenue

What is 23andMe’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of 23andMe was Consumer Services. This segment made a revenue of $202.31M, representing 32.42% of the company's total revenue.